Colforsin
Alternative Names: ForskolinLatest Information Update: 24 Oct 2021
At a glance
- Originator Aventis
- Class Antiasthmatics; Antiglaucomas; Antihypertensives; Antihypotensives; Cardiotonics; Diterpenes
- Mechanism of Action Adenylate cyclase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Heart failure; Ischaemic heart disorders
Most Recent Events
- 17 Aug 2007 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 28 Apr 1995 Preclinical development for Cancer in USA (unspecified route)